CD38 and Miyoshi myopathy: CD38, a 45 kDa transmembrane glycoprotein receptor, is highly expressed on 95–100% of malignant plasma cells and at relatively low levels on normal cells,[6] presenting a promising biomarker for several types of lymphomas, particularly MM.